Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
Clinical trial NCT04759248 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04759248
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2024-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.